BioBuzz

People on the Move: Justin Starzyk Named Chief Executive Officer of Velocity Clinical Research

Velocity Clinical Research has appointed Justin Starzyk as Chief Executive Officer, succeeding Paul Evans, who is ...
BioBuzz

People on the Move: Ben Letham Appointed to Claritev’s Board of Directors

Claritev has appointed Ben Letham to its Board of Directors, effective September 14, 2026. “Claritev is fortunate to add a ...
BioBuzz

Gaithersburg’s Autolus Wins FDA RMAT Status to Push Its Approved Leukemia CAR-T Into Lupus

Autolus Therapeutics plc, the commercial-stage biopharmaceutical company with dual headquarters in London and Gaithersburg, Maryland, announced on ...
BioBuzz

Gaithersburg’s Georgiamune Raises $93 Million Series B for Its Cancer and Autoimmune Pipeline

Georgiamune, a Gaithersburg, Maryland-based clinical-stage biotech with roughly 30 employees, has raised approximately $92.69 million in Series B financing ...
BioBuzz

People on the Move: Julia Puchtler Named Executive Vice President and CFO of the University of Pennsylvania Health System

Penn Medicine has named Julia Puchtler Executive Vice President and Chief Financial Officer of the University of Pennsylvania Health System (UPHS), ...
BioBuzz

UMD Researchers Land $2.5M NIH Grant to Study How Wildfire Smoke and Extreme Heat Together Affect Pregnancy

The University of Maryland School of Public Health announced on September 15, 2026 a $2.5 million grant from the National Institutes of Health to ...
BioBuzz

TEDCO Backs Frederick Biotech Sirius Biotech Ventures to Tackle KRAS Drug Resistance

TEDCO, Maryland’s economic engine for technology companies, announced a $25,000 investment in Sirius Biotech Ventures on September 15, 2026, through ...